In the field of automated medical diagnosis, malaria detection through blood microscopy constitutes one of the most complex challenges for artificial intelligence applied to global health. Traditional deep learning-based systems have critical limitations: they rely on full annotations, suffer from suppression of valid detections in dense regions, and lack cell-level spatial evidence for clinical auditing. Against this backdrop, an innovative approach emerges that decouples segmentation from classification, offering a robust and explainable solution. The proposal combines a distance transform-guided watershed algorithm, independent of annotations, with a convolutional neural network trained on individual cell crops. This design not only improves cell recovery in low-resource settings, but also incorporates Grad-CAM++ heatmaps per detected cell, providing microscopists with visual evidence supporting each prediction. This architecture represents a significant advance toward reliable, auditable, and transferable computer-aided diagnosis systems for real clinical contexts.
For organizations seeking to implement similar solutions, collaboration with experts in AI for business is essential. At Q2BSTUDIO, we design custom applications that integrate computer vision models, image processing, and explainable workflows. Our team combines artificial intelligence with custom software to create platforms that not only detect patterns but also offer clinical traceability. Additionally, we deploy these systems on scalable infrastructures leveraging AWS and Azure cloud services, ensuring availability and security in handling sensitive data. Cybersecurity is a pillar in every project, especially when processing medical images.
Beyond diagnosis, this type of architecture enables the creation of AI agents that assist in decision-making, automating repetitive tasks without losing precision. At the same time, the generated results can be visualized and analyzed through business intelligence services such as Power BI, integrating performance metrics and areas for improvement into interactive dashboards. At Q2BSTUDIO, we offer artificial intelligence for companies seeking to transform their processes with cutting-edge technology, from cell segmentation to explainable classification, adapting to the specific needs of each sector. The combination of these capabilities makes our company a strategic ally for high-impact projects in health and biotechnology.

.jpg)



